Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 265056, 11 pages
http://dx.doi.org/10.1155/2015/265056
Research Article

Sigma-1 Receptor Antagonist BD1047 Reduces Mechanical Allodynia in a Rat Model of Bone Cancer Pain through the Inhibition of Spinal NR1 Phosphorylation and Microglia Activation

1Department of Anesthesiology, Xuzhou Cancer Hospital, Affiliated Xuzhou Hospital, Jiangsu University, Xuzhou 221005, China
2Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical College, Xuzhou 221002, China
3Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou 221002, China
4Department of Anesthesiology, Xuzhou Children’s Hospital, Xuzhou 221006, China
5Department of Anesthesiology, Affiliated Hospital, Xuzhou Medical College, Xuzhou 221006, China
6Department of Oncology, Affiliated Hospital, Xuzhou Medical College, Xuzhou 221006, China
7Department of Pain, Affiliated Hospital, Xuzhou Medical College, Xuzhou 221006, China
8Department of Anesthesiology, Xuzhou Maternity and Child Health Hospital, Xuzhou 221009, China

Received 23 July 2015; Accepted 5 November 2015

Academic Editor: Robert LaMotte

Copyright © 2015 Shanshan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. K. Portenoy and P. Lesage, “Management of cancer pain,” The Lancet, vol. 353, no. 9165, pp. 1695–1700, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Nquyen, B. P. Lucke-Wold, S. A. Mookerjee et al., “Role of sigma-1 receptors in neurodegenerative diseases,” Journal of Pharmacological Sciences, vol. 127, no. 1, pp. 17–29, 2015. View at Publisher · View at Google Scholar
  3. K. Ruscher and T. Wieloch, “The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration,” Journal of Pharmacological Sciences, vol. 127, no. 1, pp. 30–35, 2015. View at Publisher · View at Google Scholar
  4. S. Brune, S. Pricl, and B. Wünsch, “Structure of the σ1 receptor and its ligand binding site,” Journal of Medicinal Chemistry, vol. 56, no. 24, pp. 9809–9819, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Aydar, C. P. Palmer, V. A. Klyachko, and M. B. Jackson, “The sigma receptor as a ligand-regulated auxiliary potassium channel subunit,” Neuron, vol. 34, no. 3, pp. 399–410, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Pabba, A. Y. C. Wong, N. Ahlskog et al., “NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus,” The Journal of Neuroscience, vol. 34, no. 34, pp. 11325–11338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Mtchedlishvili and J. Kapur, “A presynaptic action of the neurosteroid pregnenolone sulfate on GABAergic synaptic transmission,” Molecular Pharmacology, vol. 64, no. 4, pp. 857–864, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Hong, S. Sha, L. Zhou, C. Wang, J. Yin, and L. Chen, “Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons,” Cell Death & Disease, vol. 6, no. 7, Article ID e1832, 2015. View at Publisher · View at Google Scholar
  9. K. Hashimoto, “Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression,” Progress in Neurobiology, vol. 100, no. 1, pp. 15–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Yang, L. Chen, H. Wang, B. Xu, H. Tomimoto, and L. Chen, “Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection,” Neuropharmacology, vol. 63, no. 6, pp. 1042–1050, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Nguyen, M. J. Robson, J. R. Healy, A. L. Scandinaro, and R. R. Matsumoto, “Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan,” PLoS ONE, vol. 9, no. 2, Article ID e89985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Díaz, D. Zamanillo, J. Corbera et al., “Selective sigma-1 (sigma1) receptor antagonists: emerging target for the treatment of neuropathic pain,” Central Nervous System Agents in Medicinal Chemistry, vol. 9, no. 3, pp. 172–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D.-H. Roh, H.-W. Kim, S.-Y. Yoon et al., “Intrathecal injection of the ς1 receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain,” Anesthesiology, vol. 109, no. 5, pp. 879–889, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Lan, Y. J. Ping, W. L. Na et al., “Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model,” Molecular Pain, vol. 6, article 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-N. Wang, M. Yao, J.-P. Yang et al., “Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord,” Molecular Pain, vol. 7, article 48, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Xu, B. C. Walla, M. F. Diaz, G. N. Fuller, and H. B. Gutstein, “Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance,” Anesthesia and Analgesia, vol. 103, no. 3, pp. 714–720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Chaplan, F. W. Bach, J. W. Pogrel, J. M. Chung, and T. L. Yaksh, “Quantitative assessment of tactile allodynia in the rat paw,” Journal of Neuroscience Methods, vol. 53, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-Y. Moon, D.-H. Roh, S.-Y. Yoon et al., “Sigma-1 receptor-mediated increase in spinal p38 MAPK phosphorylation leads to the induction of mechanical allodynia in mice and neuropathic rats,” Experimental Neurology, vol. 247, pp. 383–391, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-Y. Yoon, D.-H. Roh, H.-S. Seo et al., “An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor,” Neuropharmacology, vol. 59, no. 6, pp. 460–467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. A. G. Mensah-Nyagan, S. Saredi, V. Schaeffer et al., “Assessment of neuroactive steroid formation in diabetic rat spinal cord using high-performance liquid chromatography and continuous flow scintillation detection,” Neurochemistry International, vol. 52, no. 4-5, pp. 554–559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Patte-Mensah and A. G. Mensah-Nyagan, “Peripheral neuropathy and neurosteroid formation in the central nervous system,” Brain Research Reviews, vol. 57, no. 2, pp. 454–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Kibaly, L. Meyer, C. Patte-Mensah, and A. G. Mensah-Nyagan, “Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord,” The FASEB Journal, vol. 22, no. 1, pp. 93–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-Y. Yoon, D.-H. Roh, H.-S. Seo et al., “Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABAA receptors,” British Journal of Pharmacology, vol. 157, no. 4, pp. 666–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Vyklicky, M. Korinek, T. Smejkalova et al., “Structure, function, and pharmacology of NMDA receptor channels,” Physiological Research, vol. 63, supplement 1, pp. S191–S203, 2014. View at Google Scholar · View at Scopus
  26. E. Shohami and A. Biegon, “Novel approach to the role of NMDA receptors in traumatic brain injury,” CNS & Neurological Disorders—Drug Targets, vol. 13, no. 4, pp. 567–573, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Liu, W.-T. Liu, Y.-P. Liu et al., “Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents,” Cancer Research, vol. 71, no. 13, pp. 4392–4402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Latremoliere and C. J. Woolf, “Central sensitization: a generator of pain hypersensitivity by central neural plasticity,” Journal of Pain, vol. 10, no. 9, pp. 895–926, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. J. Gao and R. R. Ji, “c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?” Open Pain Journal, vol. 2, no. 1, pp. 11–17, 2009. View at Publisher · View at Google Scholar
  30. H.-W. Kim, Y.-B. Kwon, D.-H. Roh et al., “Intrathecal treatment with sigma1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice,” British Journal of Pharmacology, vol. 148, no. 4, pp. 490–498, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R.-X. Zhang, B. Liu, L. Wang et al., “Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia,” Pain, vol. 118, no. 1-2, pp. 125–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Cao and Y.-Q. Zhang, “Spinal glial activation contributes to pathological pain states,” Neuroscience and Biobehavioral Reviews, vol. 32, no. 5, pp. 972–983, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. C. I. Svensson, S. Medicherla, S. Malkmus et al., “Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain,” Pharmacology Biochemistry and Behavior, vol. 90, no. 4, pp. 664–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. X.-H. Jin, L.-N. Wang, J.-L. Zuo, J.-P. Yang, and S.-L. Liu, “P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain,” Journal of Neuroscience Research, vol. 92, no. 12, pp. 1690–1702, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Dong, Y.-K. Tian, H.-B. Xiang, X.-B. Tian, and X.-G. Jin, “The cellular location and significance of p38α/β isoforms in the lumbar spinal cord of the bone cancer pain rats,” Zhonghua Yi Xue Za Zhi, vol. 87, no. 1, pp. 53–57, 2007. View at Google Scholar · View at Scopus
  36. C. Zhou, X. Shi, H. Huang, Y. Zhu, and Y. Wu, “Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury,” Anesthesia and analgesia, vol. 118, no. 5, pp. 1090–1096, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Kim, A. K. Myung, I.-H. Cho et al., “A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity,” The Journal of Biological Chemistry, vol. 282, no. 20, pp. 14975–14983, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Liu, H. Bu, C. Liu et al., “Inhibition of glial activation in rostral ventromedial medulla attenuates mechanical allodynia in a rat model of cancer-induced bone pain,” Journal of Huazhong University of Science and Technology Medical Science, vol. 32, no. 2, pp. 291–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. C. E. Constantin, N. Mair, C. A. Sailer et al., “Endogenous tumor necrosis factor α (TNFα) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model,” The Journal of Neuroscience, vol. 28, no. 19, pp. 5072–5081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Liu, J. Yang, L. Wang et al., “Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms,” Brain Research, vol. 1346, pp. 213–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R.-X. Zhang, B. Liu, A. Li et al., “Interleukin 1β facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation,” Neuroscience, vol. 154, no. 4, pp. 1533–1538, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Gekker, S. Hu, W. S. Sheng, R. B. Rock, J. R. Lokensgard, and P. K. Peterson, “Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-β1,” International Immunopharmacology, vol. 6, no. 6, pp. 1029–1033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. H. Yao, Y. Yang, K. J. Kim et al., “Molecular mechanisms involving sigma receptor-mediated induction of MCP-1: implication for increased monocyte transmigration,” Blood, vol. 115, no. 23, pp. 4951–4962, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. A. Hall, Y. Herrera, C. T. Ajmo, J. Cuevas, and K. R. Pennypacker, “Sigma receptors suppress multiple aspects of microglial activation,” Glia, vol. 57, no. 7, pp. 744–754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Ruscher, A. R. Inácio, K. Valind, A. Rowshan Ravan, E. Kuric, and T. Wieloch, “Effects of the sigma-1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)-piperazine dihydro-chloride on inflammation after stroke,” PLoS ONE, vol. 7, no. 9, Article ID e45118, 2012. View at Publisher · View at Google Scholar · View at Scopus